ClinicalTrials.gov
ClinicalTrials.gov Menu

30-Day Trial of Oral Valtrex or Valtrex Plus Aspirin on Shedding of HSV DNA in Tears and Saliva of Volunteers

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00587496
Recruitment Status : Unknown
Verified December 2007 by National Eye Institute (NEI).
Recruitment status was:  Recruiting
First Posted : January 7, 2008
Last Update Posted : January 7, 2008
Sponsor:
Information provided by:
National Eye Institute (NEI)

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Unknown
  Estimated Primary Completion Date : July 2008
  Estimated Study Completion Date : July 2008
Publications:
Anon. New indications. Valtrex. FDA Drug Approvals 38:572-573, 2003.
Sheskin DJ. Handbook of Parametric and Nonparametric tatistical Procedures. 2nd Edition. Chapman & Hall/CRC, Boca Raton, FL pp. 982,2000.